{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:30:04Z","timestamp":1791088204152,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.mol.0000217892.00618.54","type":"journal-article","created":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T04:03:12Z","timestamp":1141876992000},"page":"122-127","source":"Crossref","is-referenced-by-count":86,"title":["APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency"],"prefix":"10.1097","volume":"17","author":[{"given":"Sebastiano","family":"Calandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Priore","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Tarugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.CIR.97.11.1029","article-title":"Triglyceride concentration and ischemic heart disease. An eight-year follow-up in the Copenhagen Male Study","volume":"97","author":"Jeppesen","year":"1998","journal-title":"Circulation"},{"key":"R2-4-20210205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.0000081777.17879.85","article-title":"Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia. A case\u2013control comparison from the National Heart, Lung, and Blood Institute Family Heart Study","volume":"108","author":"Hopkins","year":"2003","journal-title":"Circulation"},{"key":"R3-4-20210205","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2004.11.062","article-title":"Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease","volume":"45","author":"Hopkins","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R4-4-20210205","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1161\/01.CIR.99.22.2901","article-title":"Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis","volume":"99","author":"Wittrup","year":"1999","journal-title":"Circulation"},{"key":"R5-4-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00539-1","article-title":"The apoAI-CIII-AIV gene cluster","volume":"157","author":"Groenendijk","year":"2001","journal-title":"Atherosclerosis"},{"key":"R6-4-20210205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)41611-6","article-title":"Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis","volume":"33","author":"Dallongeville","year":"1992","journal-title":"J Lipid Res"},{"key":"R7-4-20210205","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M106888200","article-title":"Apolipoprotein A-V. A novel apolipoprotein associated with an early phase of liver regeneration","volume":"276","author":"van der Vliet","year":"2001","journal-title":"J Biol Chem"},{"key":"R8-4-20210205","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"R9-4-20210205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.ATV.0000054194.78240.45","article-title":"Apolipoportein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice","volume":"23","author":"Pennacchio","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-4-20210205","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0006-291X(02)00808-2","article-title":"Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice","volume":"295","author":"van der Vliet","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"R11-4-20210205","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","article-title":"Relative contribution of variation within the apoC3\/A4\/A5 gene cluster in determining plasma triglycerides","volume":"11","author":"Talmud","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R12-4-20210205","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1194\/jlr.M200480-JLR200","article-title":"Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids","volume":"44","author":"Aouizerat","year":"2003","journal-title":"J Lipid Res"},{"key":"R13-4-20210205","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1194\/jlr.M300251-JLR200","article-title":"The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore","volume":"44","author":"Lai","year":"2003","journal-title":"J Lipid Res"},{"key":"R14-4-20210205","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-0004.2004.00251.x","article-title":"Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population","volume":"65","author":"Li","year":"2004","journal-title":"Clin Genet"},{"key":"R15-4-20210205","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1194\/jlr.M400437-JLR200","article-title":"APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study","volume":"46","author":"Klos","year":"2005","journal-title":"J Lipid Res"},{"key":"R17-4-20210205","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.RES.0000124922.61830.F0","article-title":"Association of the APOLIPOPROTEIN A1\/C3\/A4\/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia","volume":"94","author":"Mar","year":"2004","journal-title":"Circ Res"},{"key":"R18-4-20210205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.ATV.0000099881.83261.D4","article-title":"Linkage and association between distinct variants of the APOA1\/C3\/A4\/A5 gene cluster and familial combined hyperlipidemia","volume":"24","author":"Eichenbaum-Voline","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R19-4-20210205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0009-9163.2004.00199.x","article-title":"The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction","volume":"65","author":"Hubacek","year":"2004","journal-title":"Clin Genet"},{"key":"R20-4-20210205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2003.12.003","article-title":"Z. polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease","volume":"173","author":"Szalai","year":"2004","journal-title":"Atherosclerosis"},{"key":"R21-4-20210205","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1194\/jlr.M400192-JLR200","article-title":"Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study","volume":"45","author":"Lai","year":"2004","journal-title":"J Lipid Res"},{"key":"R22-4-20210205","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1194\/jlr.M300458-JLR200","article-title":"APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study","volume":"45","author":"Talmud","year":"2004","journal-title":"J Lipid Res"},{"key":"R25-4-20210205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1373\/clinchem.2004.040824","article-title":"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and Chylomicrons, and circulates at very low concentrations compared with other apolipoproteins","volume":"51","author":"O'Brien","year":"2005","journal-title":"Clin Chem"},{"key":"R26-4-20210205","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1194\/jlr.D500018-JLR200","article-title":"A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration","volume":"46","author":"Ishihara","year":"2005","journal-title":"J Lipid Res"},{"key":"R27-4-20210205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(03)14234-1","article-title":"Dyslipidaemia","volume":"362","author":"Durrington","year":"2003","journal-title":"Lancet"},{"key":"R28-4-20210205","first-page":"2789","article-title":"Familial lipoprotein lipase deficiency, apoC-II deficiency and hepatic lipase deficiency","author":"Brunzell","year":"2001"},{"key":"R29-4-20210205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Priore Oliva","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-4-20210205","doi-asserted-by":"crossref","first-page":"34438","DOI":"10.1074\/jbc.M303784200","article-title":"Structure and interfacial properties of human apolipoprotein A-V","volume":"278","author":"Weinberg","year":"2003","journal-title":"J Biol Chem"},{"key":"R31-4-20210205","doi-asserted-by":"crossref","first-page":"25383","DOI":"10.1074\/jbc.M501589200","article-title":"Apolipoprotein A-V heparin interactions. Implications for plasma lipoprotein metabolism","volume":"280","author":"Lookene","year":"2005","journal-title":"J Biol Chem"},{"key":"R32-4-20210205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1034\/j.1399-0004.2000.570209.x","article-title":"Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302 > Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL Olbia)","volume":"57","author":"Bertolini","year":"2000","journal-title":"Clin Genet"},{"key":"R33-4-20210205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0163-7258(96)00005-8","article-title":"Molecular pathobiology of the human lipoprotein lipase gene","volume":"70","author":"Murthy","year":"1996","journal-title":"Pharmacol Ther"},{"key":"R35-4-20210205","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment","volume":"115","author":"Marcais","year":"2005","journal-title":"J Clin Invest"},{"key":"R36-4-20210205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0021-9150(02)00252-6","article-title":"The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese","volume":"165","author":"Nabika","year":"2002","journal-title":"Atherosclerosis"},{"key":"R37-4-20210205","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels","volume":"24","author":"Pennacchio","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R38-4-20210205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1034\/j.1399-0004.2003.00063.x","article-title":"APOA5-1131 T > C polymorphism is associated with triglyceride levels in Chinese men","volume":"63","author":"Baum","year":"2003","journal-title":"Clin Genet"},{"key":"R39-4-20210205","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ygeno.2003.11.016","article-title":"Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11","volume":"83","author":"Oliver","year":"2004","journal-title":"Genomics"},{"key":"R40-4-20210205","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.0000186189.26141.12","article-title":"Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants","volume":"25","author":"Grosskopf","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R41-4-20210205","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","author":"Merkel","year":"2005","journal-title":"J Biol Chem"},{"key":"R42-4-20210205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2004.05.003","article-title":"Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5","volume":"319","author":"Fruchart-Najib","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R43-4-20210205","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1021\/bi034509t","article-title":"Structure\u2013function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis","volume":"42","author":"Beckstead","year":"2003","journal-title":"Biochemistry"},{"key":"R44-4-20210205","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"J Biol Chem"},{"key":"R45-4-20210205","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI26712","article-title":"Give me A5 for lipoprotein hydrolysis!","volume":"115","author":"Merkel","year":"2005","journal-title":"J Clin Invest"},{"key":"R46-4-20210205","doi-asserted-by":"crossref","first-page":"25468","DOI":"10.1074\/jbc.M301302200","article-title":"The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-\u03b1 and contains a novel farnesoid X-activated receptor response elements","volume":"278","author":"Prieur","year":"2003","journal-title":"J Biol Chem"},{"key":"R47-4-20210205","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1074\/jbc.M212191200","article-title":"Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor \u03b1 activators","volume":"278","author":"Vu-Dac","year":"2003","journal-title":"J Biol Chem"},{"key":"R48-4-20210205","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1194\/jlr.C500010-JLR200","article-title":"Administration of a PPAR\u03b1 agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V\/apolipoprotein C-III ratio","volume":"46","author":"Schultze","year":"2005","journal-title":"J Lipid Res"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006534-200603000-00036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:18:35Z","timestamp":1785856715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00041433-200604000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mol.0000217892.00618.54","relation":{},"ISSN":["0957-9672"],"issn-type":[{"value":"0957-9672","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}